FundedIQ
Artificial Intelligence

Gnosko Bio: Funding, Investors & Team (Sep 2026)

Gnosko Bio is a biotechnology company that provides real-time tracking for all products and samples, as well as automated ordering to increase profits for their clients. The company also expresses appreciation for science pioneers and healthcare workers, showing a commitment to advancing science and improving healthcare.

gnoskobio.com LinkedIn Wayne, United States 11-50 employees
Biotechnology Machine Learning Medical Device B2B
Total raised
$250k
Rounds
2
Latest
Undisclosed round
Oct 2025

Gnosko Bio has raised $250k across 2 funding rounds on record, the most recent an undisclosed round of $150k announced in Oct 2025.

That round is below the $5.5M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.

Gnosko Bio Company Profile and Key Stats

Total funding raised
$250k
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$150k in Oct 2025
Employees
11-50
reported band
Headquarters
Wayne, United States

Latest funding round on record: Oct 2025.

Gnosko Bio Funding Rounds

Date
Round
Amount
Undisclosed round
$150k
Seed
$100k

Gnosko Bio raised $100k in a Seed announced in Jul 2024.

1.3 years later, an undisclosed round of $150k was announced in Oct 2025.

Gnosko Bio Founders and Leadership Team

Name
Role
Contact
Wills Wendel
Founder
Locked

Contact details for the Gnosko Bio team: 1 of 1 has an email address on file.

Start 14-day free trial →

Gnosko Bio Funding Compared to Other Artificial Intelligence Startups

Segment
Companies
Median round

Gnosko Bio's latest round of $150k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Gnosko Bio in Artificial Intelligence and Wayne

Companies Similar to Gnosko Bio

Series A $20.0M

Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…

Series E $156M

Instinct is an artificial intelligence startup developing AI technology.

Series B $250M

Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…

Undisclosed round $15.0M

Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…

Series A $8.0M

Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…

Series A $150M

Gatik, a new company, is creating technology for self-driving trucks that are used for short-distance…

Series D $200M

Generalist AI develops AI and robotics technologies focused on enabling robots to perform physical tasks in…

Series B $200M

Quintessent is a start-up in Santa Barbara that specializes in bringing quantum dot-based lasers and photonic…

Series A $40.0M

Contact: Cardiosense is building a physiological waveform data platform that leverages novel multi-modal…

Undisclosed round $26.1M

Thunder is a Cloud computing to democratize access to GPUs and solve the ongoing GPU shortage. Decentralized…

Series A $13.0M

Deepgram helps enterprises unlock the potential of their audio data with custom trained speech recognition…

Series C

Gnosko Bio Funding FAQs

What does Gnosko Bio do?

Gnosko Bio is a biotechnology company that provides real-time tracking for all products and samples, as well as automated ordering to increase profits for their clients. The company also expresses appreciation for science pioneers and healthcare workers, showing a commitment to advancing science and improving healthcare.

How much funding has Gnosko Bio raised?

Gnosko Bio has raised $250k across 2 rounds on record. The most recent is an undisclosed round of $150k announced in Oct 2025.

When did Gnosko Bio last raise funding?

Gnosko Bio's most recent funding round on record is an undisclosed round of $150k, announced in Oct 2025.

Who founded Gnosko Bio?

FundedIQ lists Wills Wendel (Founder) at Gnosko Bio.

Where is Gnosko Bio headquartered?

Gnosko Bio is based in Wayne, Pennsylvania, United States.

How many employees does Gnosko Bio have?

Gnosko Bio is in the 11-50 employee band.

How does Gnosko Bio's funding compare to other Artificial Intelligence startups?

Gnosko Bio's latest round of $150k is below the $5.5M median round size for Artificial Intelligence companies on FundedIQ across 7,233 tracked companies over the last two years.

About FundedIQ's Gnosko Bio Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gnosko Bio is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.